Oral Diseases (2011) 17, 194–199 Objectives: Bisphosphonate‐associated osteonecrosis of
the jaw (BP‐ONJ) is a side effect in patients being treated with bisphosphonates. The …

Numerous factors can affect skeletal regeneration, including the extent of bone injury,
mechanical loading, inflammation and exogenous molecules. Bisphosphonates are …

PURPOSE: Because few treatment options exist for bisphosphonate-related osteonecrosis
of the jaw (BRONJ), developing methods of early detection and prevention is vital …

Clinically, bisphosphonate-related osteonecrosis (BRON) only occurs in the jaw (BRONJ).
We aimed to determine differences between the jaw and other bones, as well as the …

Objectives Characterize the cell profile and immunostaining of proinflammatory markers in
an experimental model of bisphosphonate‐related osteonecrosis of the jaw (BRONJ) …

Purpose Bisphosphonates (BPs) are widely used for the management of bone diseases
such as osteoporosis and bone malignancy. However, osteonecrosis of the jaws (ONJ) is a …

Background Bisphosphonate‐related osteonecrosis of the jaw (BRONJ) is a known side
effect of the therapy with bisphosphonates. No specific pathologic aspects or histological …

Though osteonecrosis of the jaw (ONJ) is temporally‐associated with the use of nitrogen‐
containing bisphosphonates (N‐BPs), a cause‐and‐effect relationship has not yet been …

Background Osteonecrosis of the jaws is recognised as a serious complication for patients
receiving bisphosphonates. The anti-angiogenic effects of bisphosphonates have been …

Objective Aim of this study was to investigate the effect of vitamin-D3 on the osteonecrosis of
bone that was induced after tooth extraction was conducted on rats that were given …